131 related articles for article (PubMed ID: 6699661)
1. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy.
Cassileth PA; Gerson SL; Bonner H; Neiman RS; Lusk EJ; Hurwitz S
J Clin Oncol; 1984 Feb; 2(2):107-11. PubMed ID: 6699661
[TBL] [Abstract][Full Text] [Related]
2. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
3. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.
Cassileth PA; Begg CB; Silber R; Spiers A; Burkart PT; Scharfman W; Knospe WH; Bennett JM; Mazza JJ; Oken MM
Cancer Treat Rep; 1987 Feb; 71(2):137-40. PubMed ID: 3802110
[TBL] [Abstract][Full Text] [Related]
4. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
[TBL] [Abstract][Full Text] [Related]
5. Leukemic infiltration of the testes in acute nonlymphocytic leukemia.
Wagner VM; Baehner RL
Med Pediatr Oncol; 1984; 12(3):166-8. PubMed ID: 6727774
[TBL] [Abstract][Full Text] [Related]
6. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL).
Amadori S; Petti MC; De Francesco A; Chierichini A; Mastrovincenzo C; Testa MG; Mandelli F
Cancer; 1978 Mar; 41(3):1154-60. PubMed ID: 638960
[TBL] [Abstract][Full Text] [Related]
8. A technique to quantify cytoreduction in the bone marrow induced by cytotoxic chemotherapy.
Blumenreich MS; Strife A; Clarkson BD
J Clin Oncol; 1983 Sep; 1(9):552-8. PubMed ID: 6668515
[TBL] [Abstract][Full Text] [Related]
9. Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
Dutcher JP; Wiernik PH; Markus S; Weinberg V; Schiffer CA; Harwood KV
Leukemia; 1988 Jul; 2(7):413-9. PubMed ID: 3393023
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation in relapsed adult acute leukemia.
Dicke KA; Zander AR; Spitzer G; Verma DS; Peters LJ; Vellekoop L; Thomson S; Stewart D; Hester JP; McCredie KB
Exp Hematol; 1979; 7 Suppl 5():170-87. PubMed ID: 400685
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow scintigraphy in the evaluation of acute nonlymphocytic leukemia.
Hoppin EC; Lewis JP; DeNardo SJ
Clin Nucl Med; 1979 Jul; 4(7):296-301. PubMed ID: 466906
[TBL] [Abstract][Full Text] [Related]
12. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of myelonecrosis after induction therapy in acute leukemia.
Cassileth PA; Brooks JS
Cancer; 1987 Nov; 60(10):2363-5. PubMed ID: 3311345
[TBL] [Abstract][Full Text] [Related]
14. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
Yamada M; Wasserman R; Lange B; Reichard BA; Womer RB; Rovera G
N Engl J Med; 1990 Aug; 323(7):448-55. PubMed ID: 2095753
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the growth of leukemic cells in vitro to the outcome of therapy for acute nonlymphocytic leukemia.
Preisler HD; Azarnia N; Marinello M
Cancer Res; 1984 Apr; 44(4):1712-7. PubMed ID: 6704977
[TBL] [Abstract][Full Text] [Related]
17. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.
Fialkow PJ; Singer JW; Raskind WH; Adamson JW; Jacobson RJ; Bernstein ID; Dow LW; Najfeld V; Veith R
N Engl J Med; 1987 Aug; 317(8):468-73. PubMed ID: 3614291
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
19. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse.
Jehn U; Wachholz K
Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the unmaintained remission of acute non-lymphoblastic leukemia by serial bone marrow cultures.
Bohinjec J
Leuk Res; 1991; 15(6):473-9. PubMed ID: 1861533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
